nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ABCC4—Methotrexate—psoriatic arthritis	0.0299	0.115	CbGbCtD
Sunitinib—ABCC2—Dexamethasone—psoriatic arthritis	0.0221	0.0848	CbGbCtD
Sunitinib—ABCG2—Dexamethasone—psoriatic arthritis	0.02	0.0767	CbGbCtD
Sunitinib—ABCB1—Methylprednisolone—psoriatic arthritis	0.0191	0.0731	CbGbCtD
Sunitinib—ABCC2—Methotrexate—psoriatic arthritis	0.0178	0.0682	CbGbCtD
Sunitinib—ABCG2—Methotrexate—psoriatic arthritis	0.0161	0.0616	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0148	0.0566	CbGbCtD
Sunitinib—CYP3A7—Dexamethasone—psoriatic arthritis	0.0148	0.0566	CbGbCtD
Sunitinib—ABCB1—Betamethasone—psoriatic arthritis	0.0124	0.0475	CbGbCtD
Sunitinib—ABCB1—Prednisolone—psoriatic arthritis	0.0122	0.0469	CbGbCtD
Sunitinib—ABCB1—Prednisone—psoriatic arthritis	0.0115	0.0443	CbGbCtD
Sunitinib—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0114	0.0438	CbGbCtD
Sunitinib—CYP3A5—Dexamethasone—psoriatic arthritis	0.0111	0.0425	CbGbCtD
Sunitinib—PKN1—synovial membrane of synovial joint—psoriatic arthritis	0.0108	0.0606	CbGeAlD
Sunitinib—CYP3A4—Triamcinolone—psoriatic arthritis	0.00865	0.0332	CbGbCtD
Sunitinib—BMP2K—synovial membrane of synovial joint—psoriatic arthritis	0.00748	0.042	CbGeAlD
Sunitinib—CYP3A4—Betamethasone—psoriatic arthritis	0.00742	0.0285	CbGbCtD
Sunitinib—CYP3A4—Prednisolone—psoriatic arthritis	0.00733	0.0281	CbGbCtD
Sunitinib—ABCB1—Dexamethasone—psoriatic arthritis	0.00721	0.0276	CbGbCtD
Sunitinib—CYP3A4—Prednisone—psoriatic arthritis	0.00692	0.0265	CbGbCtD
Sunitinib—ABCB1—Methotrexate—psoriatic arthritis	0.00579	0.0222	CbGbCtD
Sunitinib—DYRK2—skin of body—psoriatic arthritis	0.00512	0.0288	CbGeAlD
Sunitinib—MYLK2—tendon—psoriatic arthritis	0.00458	0.0258	CbGeAlD
Sunitinib—CYP3A4—Dexamethasone—psoriatic arthritis	0.00432	0.0166	CbGbCtD
Sunitinib—HUNK—tendon—psoriatic arthritis	0.00347	0.0195	CbGeAlD
Sunitinib—MYLK4—tendon—psoriatic arthritis	0.00295	0.0166	CbGeAlD
Sunitinib—MYLK3—tendon—psoriatic arthritis	0.00286	0.0161	CbGeAlD
Sunitinib—CDK16—skin of body—psoriatic arthritis	0.00272	0.0153	CbGeAlD
Sunitinib—NIM1K—tendon—psoriatic arthritis	0.00251	0.0141	CbGeAlD
Sunitinib—PRKAA2—tendon—psoriatic arthritis	0.00241	0.0135	CbGeAlD
Sunitinib—STK17B—tendon—psoriatic arthritis	0.00232	0.013	CbGeAlD
Sunitinib—INSR—skin of body—psoriatic arthritis	0.00221	0.0124	CbGeAlD
Sunitinib—CSNK1G2—skin of body—psoriatic arthritis	0.00214	0.012	CbGeAlD
Sunitinib—STK17A—tendon—psoriatic arthritis	0.00213	0.012	CbGeAlD
Sunitinib—CDK14—tendon—psoriatic arthritis	0.0021	0.0118	CbGeAlD
Sunitinib—LATS2—tendon—psoriatic arthritis	0.00207	0.0117	CbGeAlD
Sunitinib—MYLK—skin of body—psoriatic arthritis	0.002	0.0112	CbGeAlD
Sunitinib—CLK4—tendon—psoriatic arthritis	0.00197	0.0111	CbGeAlD
Sunitinib—SBK1—tendon—psoriatic arthritis	0.00195	0.0109	CbGeAlD
Sunitinib—STK24—skin of body—psoriatic arthritis	0.00192	0.0108	CbGeAlD
Sunitinib—PHKG1—tendon—psoriatic arthritis	0.0019	0.0107	CbGeAlD
Sunitinib—DAPK1—tendon—psoriatic arthritis	0.0019	0.0107	CbGeAlD
Sunitinib—TYRO3—skin of body—psoriatic arthritis	0.00185	0.0104	CbGeAlD
Sunitinib—RPS6KA1—tendon—psoriatic arthritis	0.00182	0.0103	CbGeAlD
Sunitinib—RIOK1—tendon—psoriatic arthritis	0.00182	0.0103	CbGeAlD
Sunitinib—MARK2—tendon—psoriatic arthritis	0.00179	0.0101	CbGeAlD
Sunitinib—TNIK—tendon—psoriatic arthritis	0.00179	0.0101	CbGeAlD
Sunitinib—SGK3—tendon—psoriatic arthritis	0.00177	0.00996	CbGeAlD
Sunitinib—ICK—tendon—psoriatic arthritis	0.00176	0.00987	CbGeAlD
Sunitinib—CHEK2—tendon—psoriatic arthritis	0.0017	0.00954	CbGeAlD
Sunitinib—NUAK1—tendon—psoriatic arthritis	0.0017	0.00954	CbGeAlD
Sunitinib—OXSR1—tendon—psoriatic arthritis	0.00168	0.00946	CbGeAlD
Sunitinib—SNRK—tendon—psoriatic arthritis	0.00168	0.00946	CbGeAlD
Sunitinib—INSR—tendon—psoriatic arthritis	0.00168	0.00946	CbGeAlD
Sunitinib—TLK2—Progesterone—Prednisolone—psoriatic arthritis	0.00167	0.276	CbGdCrCtD
Sunitinib—STK38—tendon—psoriatic arthritis	0.00165	0.00931	CbGeAlD
Sunitinib—RPS6KA2—tendon—psoriatic arthritis	0.00165	0.00931	CbGeAlD
Sunitinib—AURKC—tendon—psoriatic arthritis	0.00164	0.00923	CbGeAlD
Sunitinib—CSNK1G2—tendon—psoriatic arthritis	0.00163	0.00916	CbGeAlD
Sunitinib—PKN1—tendon—psoriatic arthritis	0.00163	0.00916	CbGeAlD
Sunitinib—PRPF4—tendon—psoriatic arthritis	0.00161	0.00903	CbGeAlD
Sunitinib—PRPF4B—tendon—psoriatic arthritis	0.00158	0.0089	CbGeAlD
Sunitinib—STK39—tendon—psoriatic arthritis	0.00156	0.00878	CbGeAlD
Sunitinib—MAP2K1—skin of body—psoriatic arthritis	0.00154	0.00868	CbGeAlD
Sunitinib—CSNK2A1—tendon—psoriatic arthritis	0.00154	0.00866	CbGeAlD
Sunitinib—CSNK1A1—skin of body—psoriatic arthritis	0.00152	0.00857	CbGeAlD
Sunitinib—PHKG2—tendon—psoriatic arthritis	0.00147	0.00825	CbGeAlD
Sunitinib—STK24—tendon—psoriatic arthritis	0.00146	0.0082	CbGeAlD
Sunitinib—DAPK2—tendon—psoriatic arthritis	0.00144	0.00811	CbGeAlD
Sunitinib—STK16—tendon—psoriatic arthritis	0.00142	0.00798	CbGeAlD
Sunitinib—CSNK1E—skin of body—psoriatic arthritis	0.00141	0.00794	CbGeAlD
Sunitinib—HIPK2—tendon—psoriatic arthritis	0.00141	0.00793	CbGeAlD
Sunitinib—HIPK3—tendon—psoriatic arthritis	0.00141	0.00793	CbGeAlD
Sunitinib—TNK1—tendon—psoriatic arthritis	0.0014	0.00785	CbGeAlD
Sunitinib—RIOK2—tendon—psoriatic arthritis	0.0014	0.00785	CbGeAlD
Sunitinib—MAP4K1—tendon—psoriatic arthritis	0.00138	0.00777	CbGeAlD
Sunitinib—MAP2K2—skin of body—psoriatic arthritis	0.00136	0.00764	CbGeAlD
Sunitinib—DAPK3—tendon—psoriatic arthritis	0.00136	0.00762	CbGeAlD
Sunitinib—CLK2—tendon—psoriatic arthritis	0.00134	0.00755	CbGeAlD
Sunitinib—MAP4K2—tendon—psoriatic arthritis	0.00134	0.00752	CbGeAlD
Sunitinib—STK3—tendon—psoriatic arthritis	0.00132	0.00742	CbGeAlD
Sunitinib—TYK2—skin of body—psoriatic arthritis	0.00131	0.00738	CbGeAlD
Sunitinib—AXL—skin of body—psoriatic arthritis	0.00126	0.00708	CbGeAlD
Sunitinib—MERTK—tendon—psoriatic arthritis	0.00124	0.00697	CbGeAlD
Sunitinib—MAP4K4—tendon—psoriatic arthritis	0.00122	0.00684	CbGeAlD
Sunitinib—FGFR2—skin of body—psoriatic arthritis	0.0012	0.00675	CbGeAlD
Sunitinib—MAP3K12—tendon—psoriatic arthritis	0.0012	0.00675	CbGeAlD
Sunitinib—JAK2—skin of body—psoriatic arthritis	0.00119	0.00672	CbGeAlD
Sunitinib—RPS6KA3—tendon—psoriatic arthritis	0.00118	0.00665	CbGeAlD
Sunitinib—FYN—skin of body—psoriatic arthritis	0.00118	0.00662	CbGeAlD
Sunitinib—CSNK1A1—tendon—psoriatic arthritis	0.00116	0.00652	CbGeAlD
Sunitinib—CLK1—tendon—psoriatic arthritis	0.00115	0.00648	CbGeAlD
Sunitinib—MAP3K3—skin of body—psoriatic arthritis	0.00115	0.00647	CbGeAlD
Sunitinib—CAMK2G—tendon—psoriatic arthritis	0.00113	0.00636	CbGeAlD
Sunitinib—BMP2K—tendon—psoriatic arthritis	0.00113	0.00636	CbGeAlD
Sunitinib—LRRK2—tendon—psoriatic arthritis	0.00112	0.00631	CbGeAlD
Sunitinib—EPHB6—skin of body—psoriatic arthritis	0.0011	0.00619	CbGeAlD
Sunitinib—PTK2B—tendon—psoriatic arthritis	0.00109	0.00614	CbGeAlD
Sunitinib—CSNK1E—tendon—psoriatic arthritis	0.00107	0.00604	CbGeAlD
Sunitinib—FGFR1—tendon—psoriatic arthritis	0.00107	0.00604	CbGeAlD
Sunitinib—IRAK4—tendon—psoriatic arthritis	0.00106	0.00595	CbGeAlD
Sunitinib—MAP2K2—tendon—psoriatic arthritis	0.00103	0.00582	CbGeAlD
Sunitinib—ULK3—tendon—psoriatic arthritis	0.00103	0.00582	CbGeAlD
Sunitinib—MAP3K7—tendon—psoriatic arthritis	0.00102	0.00572	CbGeAlD
Sunitinib—TBK1—tendon—psoriatic arthritis	0.00101	0.00566	CbGeAlD
Sunitinib—TYK2—tendon—psoriatic arthritis	0.000999	0.00562	CbGeAlD
Sunitinib—IRAK1—tendon—psoriatic arthritis	0.000986	0.00555	CbGeAlD
Sunitinib—RPS6KB1—tendon—psoriatic arthritis	0.000968	0.00544	CbGeAlD
Sunitinib—RET—tendon—psoriatic arthritis	0.000962	0.00541	CbGeAlD
Sunitinib—FGR—tendon—psoriatic arthritis	0.000962	0.00541	CbGeAlD
Sunitinib—AXL—tendon—psoriatic arthritis	0.000958	0.00539	CbGeAlD
Sunitinib—SLK—tendon—psoriatic arthritis	0.000922	0.00519	CbGeAlD
Sunitinib—CSF1R—skin of body—psoriatic arthritis	0.000918	0.00516	CbGeAlD
Sunitinib—JAK2—tendon—psoriatic arthritis	0.000909	0.00511	CbGeAlD
Sunitinib—FYN—tendon—psoriatic arthritis	0.000897	0.00504	CbGeAlD
Sunitinib—MAP4K5—tendon—psoriatic arthritis	0.000876	0.00493	CbGeAlD
Sunitinib—MAP3K3—tendon—psoriatic arthritis	0.000876	0.00493	CbGeAlD
Sunitinib—FLT1—tendon—psoriatic arthritis	0.000847	0.00476	CbGeAlD
Sunitinib—EPHB6—tendon—psoriatic arthritis	0.000837	0.00471	CbGeAlD
Sunitinib—KIT—skin of body—psoriatic arthritis	0.000834	0.00469	CbGeAlD
Sunitinib—PDGFRB—skin of body—psoriatic arthritis	0.000814	0.00458	CbGeAlD
Sunitinib—YES1—tendon—psoriatic arthritis	0.000809	0.00455	CbGeAlD
Sunitinib—STK10—tendon—psoriatic arthritis	0.000802	0.00451	CbGeAlD
Sunitinib—TAOK3—tendon—psoriatic arthritis	0.000799	0.00449	CbGeAlD
Sunitinib—PDGFRA—tendon—psoriatic arthritis	0.000794	0.00446	CbGeAlD
Sunitinib—KDR—tendon—psoriatic arthritis	0.000716	0.00403	CbGeAlD
Sunitinib—MAP2K5—tendon—psoriatic arthritis	0.000716	0.00403	CbGeAlD
Sunitinib—CSF1R—tendon—psoriatic arthritis	0.000699	0.00393	CbGeAlD
Sunitinib—PDGFRB—tendon—psoriatic arthritis	0.00062	0.00349	CbGeAlD
Sunitinib—CSNK1E—Danazol—Prednisone—psoriatic arthritis	0.000538	0.0888	CbGdCrCtD
Sunitinib—ABCC4—tendon—psoriatic arthritis	0.000494	0.00278	CbGeAlD
Sunitinib—ABCC2—tendon—psoriatic arthritis	0.000478	0.00269	CbGeAlD
Sunitinib—CSNK1E—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000376	0.0621	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000376	0.0621	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Dexamethasone—psoriatic arthritis	0.00037	0.0611	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Betamethasone—psoriatic arthritis	0.00037	0.0611	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Triamcinolone—psoriatic arthritis	0.000362	0.0597	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000362	0.0597	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—psoriatic arthritis	0.000343	0.0567	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—psoriatic arthritis	0.000343	0.0567	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisolone—psoriatic arthritis	0.000335	0.0553	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisolone—psoriatic arthritis	0.000335	0.0553	CbGdCrCtD
Sunitinib—Eye disorder—Betamethasone—psoriatic arthritis	0.000279	0.001	CcSEcCtD
Sunitinib—Eye disorder—Dexamethasone—psoriatic arthritis	0.000279	0.001	CcSEcCtD
Sunitinib—Back pain—Triamcinolone—psoriatic arthritis	0.000277	0.000995	CcSEcCtD
Sunitinib—CHEK2—Danazol—Prednisone—psoriatic arthritis	0.000275	0.0454	CbGdCrCtD
Sunitinib—Angiopathy—Dexamethasone—psoriatic arthritis	0.000271	0.000973	CcSEcCtD
Sunitinib—Angiopathy—Betamethasone—psoriatic arthritis	0.000271	0.000973	CcSEcCtD
Sunitinib—Convulsion—Prednisolone—psoriatic arthritis	0.00027	0.00097	CcSEcCtD
Sunitinib—Hypertension—Prednisolone—psoriatic arthritis	0.000269	0.000966	CcSEcCtD
Sunitinib—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000266	0.000958	CcSEcCtD
Sunitinib—Arrhythmia—Betamethasone—psoriatic arthritis	0.000266	0.000958	CcSEcCtD
Sunitinib—Pancreatitis—Methotrexate—psoriatic arthritis	0.000266	0.000956	CcSEcCtD
Sunitinib—Bradycardia—Prednisone—psoriatic arthritis	0.000264	0.000951	CcSEcCtD
Sunitinib—Alopecia—Dexamethasone—psoriatic arthritis	0.000263	0.000948	CcSEcCtD
Sunitinib—Alopecia—Betamethasone—psoriatic arthritis	0.000263	0.000948	CcSEcCtD
Sunitinib—Angioedema—Triamcinolone—psoriatic arthritis	0.000261	0.00094	CcSEcCtD
Sunitinib—Haemoglobin—Prednisone—psoriatic arthritis	0.000261	0.000939	CcSEcCtD
Sunitinib—Angioedema—Methylprednisolone—psoriatic arthritis	0.000261	0.000938	CcSEcCtD
Sunitinib—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00026	0.000935	CcSEcCtD
Sunitinib—Haemorrhage—Prednisone—psoriatic arthritis	0.00026	0.000934	CcSEcCtD
Sunitinib—Erythema—Dexamethasone—psoriatic arthritis	0.00026	0.000934	CcSEcCtD
Sunitinib—Erythema—Betamethasone—psoriatic arthritis	0.00026	0.000934	CcSEcCtD
Sunitinib—Pancytopenia—Methotrexate—psoriatic arthritis	0.000257	0.000926	CcSEcCtD
Sunitinib—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000255	0.000918	CcSEcCtD
Sunitinib—Oedema—Prednisolone—psoriatic arthritis	0.000254	0.000913	CcSEcCtD
Sunitinib—Neutropenia—Methotrexate—psoriatic arthritis	0.000254	0.000912	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000252	0.000906	CcSEcCtD
Sunitinib—Shock—Prednisolone—psoriatic arthritis	0.00025	0.000899	CcSEcCtD
Sunitinib—Cough—Triamcinolone—psoriatic arthritis	0.00025	0.000898	CcSEcCtD
Sunitinib—Convulsion—Triamcinolone—psoriatic arthritis	0.000248	0.000892	CcSEcCtD
Sunitinib—Convulsion—Methylprednisolone—psoriatic arthritis	0.000247	0.00089	CcSEcCtD
Sunitinib—Hypertension—Triamcinolone—psoriatic arthritis	0.000247	0.000888	CcSEcCtD
Sunitinib—Hypertension—Methylprednisolone—psoriatic arthritis	0.000246	0.000887	CcSEcCtD
Sunitinib—Myalgia—Triamcinolone—psoriatic arthritis	0.000244	0.000876	CcSEcCtD
Sunitinib—Pneumonia—Methotrexate—psoriatic arthritis	0.000243	0.000875	CcSEcCtD
Sunitinib—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000243	0.000874	CcSEcCtD
Sunitinib—Myalgia—Methylprednisolone—psoriatic arthritis	0.000243	0.000874	CcSEcCtD
Sunitinib—Eye disorder—Prednisone—psoriatic arthritis	0.000243	0.000873	CcSEcCtD
Sunitinib—Infestation—Methotrexate—psoriatic arthritis	0.000242	0.00087	CcSEcCtD
Sunitinib—Infestation NOS—Methotrexate—psoriatic arthritis	0.000242	0.00087	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000241	0.000868	CcSEcCtD
Sunitinib—Depression—Methotrexate—psoriatic arthritis	0.000241	0.000867	CcSEcCtD
Sunitinib—Flushing—Prednisone—psoriatic arthritis	0.000241	0.000867	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00024	0.000862	CcSEcCtD
Sunitinib—Dry mouth—Triamcinolone—psoriatic arthritis	0.000238	0.000857	CcSEcCtD
Sunitinib—Renal failure—Methotrexate—psoriatic arthritis	0.000238	0.000855	CcSEcCtD
Sunitinib—Angioedema—Dexamethasone—psoriatic arthritis	0.000237	0.000853	CcSEcCtD
Sunitinib—Angioedema—Betamethasone—psoriatic arthritis	0.000237	0.000853	CcSEcCtD
Sunitinib—Stomatitis—Methotrexate—psoriatic arthritis	0.000236	0.000848	CcSEcCtD
Sunitinib—Angiopathy—Prednisone—psoriatic arthritis	0.000236	0.000848	CcSEcCtD
Sunitinib—Immune system disorder—Prednisone—psoriatic arthritis	0.000235	0.000844	CcSEcCtD
Sunitinib—Oedema—Triamcinolone—psoriatic arthritis	0.000233	0.00084	CcSEcCtD
Sunitinib—Arrhythmia—Prednisone—psoriatic arthritis	0.000232	0.000834	CcSEcCtD
Sunitinib—Infection—Triamcinolone—psoriatic arthritis	0.000232	0.000834	CcSEcCtD
Sunitinib—Infection—Methylprednisolone—psoriatic arthritis	0.000231	0.000833	CcSEcCtD
Sunitinib—Shock—Triamcinolone—psoriatic arthritis	0.00023	0.000826	CcSEcCtD
Sunitinib—Insomnia—Prednisolone—psoriatic arthritis	0.00023	0.000826	CcSEcCtD
Sunitinib—Alopecia—Prednisone—psoriatic arthritis	0.000229	0.000825	CcSEcCtD
Sunitinib—Shock—Methylprednisolone—psoriatic arthritis	0.000229	0.000824	CcSEcCtD
Sunitinib—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000229	0.000822	CcSEcCtD
Sunitinib—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000228	0.000822	CcSEcCtD
Sunitinib—Epistaxis—Methotrexate—psoriatic arthritis	0.000228	0.00082	CcSEcCtD
Sunitinib—Paraesthesia—Prednisolone—psoriatic arthritis	0.000228	0.00082	CcSEcCtD
Sunitinib—Mental disorder—Prednisone—psoriatic arthritis	0.000227	0.000818	CcSEcCtD
Sunitinib—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000226	0.000814	CcSEcCtD
Sunitinib—Erythema—Prednisone—psoriatic arthritis	0.000226	0.000813	CcSEcCtD
Sunitinib—Malnutrition—Prednisone—psoriatic arthritis	0.000226	0.000813	CcSEcCtD
Sunitinib—Convulsion—Dexamethasone—psoriatic arthritis	0.000225	0.000809	CcSEcCtD
Sunitinib—Convulsion—Betamethasone—psoriatic arthritis	0.000225	0.000809	CcSEcCtD
Sunitinib—Hypertension—Betamethasone—psoriatic arthritis	0.000224	0.000806	CcSEcCtD
Sunitinib—Hypertension—Dexamethasone—psoriatic arthritis	0.000224	0.000806	CcSEcCtD
Sunitinib—Myalgia—Dexamethasone—psoriatic arthritis	0.000221	0.000795	CcSEcCtD
Sunitinib—Myalgia—Betamethasone—psoriatic arthritis	0.000221	0.000795	CcSEcCtD
Sunitinib—Haemoglobin—Methotrexate—psoriatic arthritis	0.000218	0.000785	CcSEcCtD
Sunitinib—Pain—Prednisolone—psoriatic arthritis	0.000217	0.000781	CcSEcCtD
Sunitinib—Haemorrhage—Methotrexate—psoriatic arthritis	0.000217	0.000781	CcSEcCtD
Sunitinib—Hepatitis—Methotrexate—psoriatic arthritis	0.000217	0.000781	CcSEcCtD
Sunitinib—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000214	0.000771	CcSEcCtD
Sunitinib—Urethral disorder—Methotrexate—psoriatic arthritis	0.000213	0.000765	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000213	0.000765	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000212	0.000764	CcSEcCtD
Sunitinib—Oedema—Dexamethasone—psoriatic arthritis	0.000212	0.000762	CcSEcCtD
Sunitinib—Oedema—Betamethasone—psoriatic arthritis	0.000212	0.000762	CcSEcCtD
Sunitinib—Insomnia—Triamcinolone—psoriatic arthritis	0.000211	0.00076	CcSEcCtD
Sunitinib—Insomnia—Methylprednisolone—psoriatic arthritis	0.000211	0.000758	CcSEcCtD
Sunitinib—Infection—Dexamethasone—psoriatic arthritis	0.00021	0.000757	CcSEcCtD
Sunitinib—Infection—Betamethasone—psoriatic arthritis	0.00021	0.000757	CcSEcCtD
Sunitinib—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00021	0.000754	CcSEcCtD
Sunitinib—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000209	0.000752	CcSEcCtD
Sunitinib—Anaemia—Prednisone—psoriatic arthritis	0.000209	0.000752	CcSEcCtD
Sunitinib—Shock—Betamethasone—psoriatic arthritis	0.000208	0.00075	CcSEcCtD
Sunitinib—Shock—Dexamethasone—psoriatic arthritis	0.000208	0.00075	CcSEcCtD
Sunitinib—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000208	0.000749	CcSEcCtD
Sunitinib—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000208	0.000747	CcSEcCtD
Sunitinib—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000208	0.000747	CcSEcCtD
Sunitinib—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000207	0.000746	CcSEcCtD
Sunitinib—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000207	0.000746	CcSEcCtD
Sunitinib—Angioedema—Prednisone—psoriatic arthritis	0.000207	0.000743	CcSEcCtD
Sunitinib—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000206	0.000739	CcSEcCtD
Sunitinib—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000205	0.000738	CcSEcCtD
Sunitinib—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000205	0.000738	CcSEcCtD
Sunitinib—Eye disorder—Methotrexate—psoriatic arthritis	0.000203	0.00073	CcSEcCtD
Sunitinib—Anorexia—Dexamethasone—psoriatic arthritis	0.000202	0.000726	CcSEcCtD
Sunitinib—Anorexia—Betamethasone—psoriatic arthritis	0.000202	0.000726	CcSEcCtD
Sunitinib—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000201	0.000725	CcSEcCtD
Sunitinib—Fatigue—Triamcinolone—psoriatic arthritis	0.000201	0.000724	CcSEcCtD
Sunitinib—Fatigue—Methylprednisolone—psoriatic arthritis	0.000201	0.000723	CcSEcCtD
Sunitinib—Pain—Triamcinolone—psoriatic arthritis	0.0002	0.000718	CcSEcCtD
Sunitinib—Angiopathy—Methotrexate—psoriatic arthritis	0.000197	0.000708	CcSEcCtD
Sunitinib—Immune system disorder—Methotrexate—psoriatic arthritis	0.000196	0.000705	CcSEcCtD
Sunitinib—Convulsion—Prednisone—psoriatic arthritis	0.000196	0.000705	CcSEcCtD
Sunitinib—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000196	0.000704	CcSEcCtD
Sunitinib—Hypertension—Prednisone—psoriatic arthritis	0.000195	0.000702	CcSEcCtD
Sunitinib—Chills—Methotrexate—psoriatic arthritis	0.000195	0.0007	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000193	0.000694	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000193	0.000694	CcSEcCtD
Sunitinib—Myalgia—Prednisone—psoriatic arthritis	0.000192	0.000692	CcSEcCtD
Sunitinib—Arthralgia—Prednisone—psoriatic arthritis	0.000192	0.000692	CcSEcCtD
Sunitinib—Alopecia—Methotrexate—psoriatic arthritis	0.000192	0.00069	CcSEcCtD
Sunitinib—Insomnia—Dexamethasone—psoriatic arthritis	0.000192	0.000689	CcSEcCtD
Sunitinib—Insomnia—Betamethasone—psoriatic arthritis	0.000192	0.000689	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000191	0.000688	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00019	0.000685	CcSEcCtD
Sunitinib—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00019	0.000684	CcSEcCtD
Sunitinib—Paraesthesia—Betamethasone—psoriatic arthritis	0.00019	0.000684	CcSEcCtD
Sunitinib—Mental disorder—Methotrexate—psoriatic arthritis	0.00019	0.000684	CcSEcCtD
Sunitinib—Erythema—Methotrexate—psoriatic arthritis	0.000189	0.00068	CcSEcCtD
Sunitinib—Malnutrition—Methotrexate—psoriatic arthritis	0.000189	0.00068	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000187	0.000673	CcSEcCtD
Sunitinib—Dyspepsia—Betamethasone—psoriatic arthritis	0.000186	0.000671	CcSEcCtD
Sunitinib—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000186	0.000671	CcSEcCtD
Sunitinib—Dysgeusia—Methotrexate—psoriatic arthritis	0.000185	0.000666	CcSEcCtD
Sunitinib—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000185	0.000664	CcSEcCtD
Sunitinib—Oedema—Prednisone—psoriatic arthritis	0.000184	0.000664	CcSEcCtD
Sunitinib—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000184	0.000662	CcSEcCtD
Sunitinib—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000184	0.000662	CcSEcCtD
Sunitinib—Decreased appetite—Betamethasone—psoriatic arthritis	0.000184	0.000662	CcSEcCtD
Sunitinib—Infection—Prednisone—psoriatic arthritis	0.000183	0.000659	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000183	0.000658	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000183	0.000658	CcSEcCtD
Sunitinib—Back pain—Methotrexate—psoriatic arthritis	0.000183	0.000657	CcSEcCtD
Sunitinib—Fatigue—Dexamethasone—psoriatic arthritis	0.000183	0.000657	CcSEcCtD
Sunitinib—Fatigue—Betamethasone—psoriatic arthritis	0.000183	0.000657	CcSEcCtD
Sunitinib—Shock—Prednisone—psoriatic arthritis	0.000181	0.000653	CcSEcCtD
Sunitinib—Pain—Betamethasone—psoriatic arthritis	0.000181	0.000652	CcSEcCtD
Sunitinib—Pain—Dexamethasone—psoriatic arthritis	0.000181	0.000652	CcSEcCtD
Sunitinib—Nervous system disorder—Prednisone—psoriatic arthritis	0.000181	0.000651	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—psoriatic arthritis	0.000179	0.000645	CcSEcCtD
Sunitinib—Anorexia—Prednisone—psoriatic arthritis	0.000176	0.000633	CcSEcCtD
Sunitinib—Anaemia—Methotrexate—psoriatic arthritis	0.000175	0.000628	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000173	0.000623	CcSEcCtD
Sunitinib—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000173	0.000623	CcSEcCtD
Sunitinib—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000172	0.000619	CcSEcCtD
Sunitinib—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000172	0.000617	CcSEcCtD
Sunitinib—Leukopenia—Methotrexate—psoriatic arthritis	0.000169	0.000608	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000168	0.000605	CcSEcCtD
Sunitinib—Dizziness—Prednisolone—psoriatic arthritis	0.000168	0.000604	CcSEcCtD
Sunitinib—Asthenia—Triamcinolone—psoriatic arthritis	0.000168	0.000603	CcSEcCtD
Sunitinib—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000167	0.000602	CcSEcCtD
Sunitinib—Abdominal pain—Betamethasone—psoriatic arthritis	0.000167	0.000602	CcSEcCtD
Sunitinib—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000167	0.000602	CcSEcCtD
Sunitinib—Body temperature increased—Betamethasone—psoriatic arthritis	0.000167	0.000602	CcSEcCtD
Sunitinib—Asthenia—Methylprednisolone—psoriatic arthritis	0.000167	0.000601	CcSEcCtD
Sunitinib—Insomnia—Prednisone—psoriatic arthritis	0.000167	0.0006	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—psoriatic arthritis	0.000166	0.000596	CcSEcCtD
Sunitinib—Pruritus—Triamcinolone—psoriatic arthritis	0.000165	0.000594	CcSEcCtD
Sunitinib—Cough—Methotrexate—psoriatic arthritis	0.000165	0.000593	CcSEcCtD
Sunitinib—Pruritus—Methylprednisolone—psoriatic arthritis	0.000165	0.000593	CcSEcCtD
Sunitinib—Convulsion—Methotrexate—psoriatic arthritis	0.000164	0.000589	CcSEcCtD
Sunitinib—Dyspepsia—Prednisone—psoriatic arthritis	0.000162	0.000584	CcSEcCtD
Sunitinib—Chest pain—Methotrexate—psoriatic arthritis	0.000161	0.000579	CcSEcCtD
Sunitinib—Myalgia—Methotrexate—psoriatic arthritis	0.000161	0.000579	CcSEcCtD
Sunitinib—Arthralgia—Methotrexate—psoriatic arthritis	0.000161	0.000579	CcSEcCtD
Sunitinib—Decreased appetite—Prednisone—psoriatic arthritis	0.00016	0.000577	CcSEcCtD
Sunitinib—Rash—Prednisolone—psoriatic arthritis	0.00016	0.000576	CcSEcCtD
Sunitinib—Dermatitis—Prednisolone—psoriatic arthritis	0.00016	0.000575	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00016	0.000575	CcSEcCtD
Sunitinib—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000159	0.000573	CcSEcCtD
Sunitinib—Fatigue—Prednisone—psoriatic arthritis	0.000159	0.000572	CcSEcCtD
Sunitinib—Headache—Prednisolone—psoriatic arthritis	0.000159	0.000572	CcSEcCtD
Sunitinib—Constipation—Prednisone—psoriatic arthritis	0.000158	0.000568	CcSEcCtD
Sunitinib—Dizziness—Triamcinolone—psoriatic arthritis	0.000154	0.000555	CcSEcCtD
Sunitinib—Dizziness—Methylprednisolone—psoriatic arthritis	0.000154	0.000554	CcSEcCtD
Sunitinib—Infection—Methotrexate—psoriatic arthritis	0.000153	0.000551	CcSEcCtD
Sunitinib—Asthenia—Betamethasone—psoriatic arthritis	0.000152	0.000547	CcSEcCtD
Sunitinib—Asthenia—Dexamethasone—psoriatic arthritis	0.000152	0.000547	CcSEcCtD
Sunitinib—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000151	0.000544	CcSEcCtD
Sunitinib—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000151	0.000543	CcSEcCtD
Sunitinib—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000151	0.000543	CcSEcCtD
Sunitinib—Nausea—Prednisolone—psoriatic arthritis	0.000151	0.000542	CcSEcCtD
Sunitinib—Pruritus—Betamethasone—psoriatic arthritis	0.00015	0.000539	CcSEcCtD
Sunitinib—Pruritus—Dexamethasone—psoriatic arthritis	0.00015	0.000539	CcSEcCtD
Sunitinib—Skin disorder—Methotrexate—psoriatic arthritis	0.00015	0.000539	CcSEcCtD
Sunitinib—Vomiting—Triamcinolone—psoriatic arthritis	0.000148	0.000534	CcSEcCtD
Sunitinib—Vomiting—Methylprednisolone—psoriatic arthritis	0.000148	0.000533	CcSEcCtD
Sunitinib—Rash—Triamcinolone—psoriatic arthritis	0.000147	0.00053	CcSEcCtD
Sunitinib—Dermatitis—Triamcinolone—psoriatic arthritis	0.000147	0.000529	CcSEcCtD
Sunitinib—Anorexia—Methotrexate—psoriatic arthritis	0.000147	0.000529	CcSEcCtD
Sunitinib—Rash—Methylprednisolone—psoriatic arthritis	0.000147	0.000528	CcSEcCtD
Sunitinib—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000147	0.000528	CcSEcCtD
Sunitinib—Headache—Triamcinolone—psoriatic arthritis	0.000146	0.000526	CcSEcCtD
Sunitinib—Headache—Methylprednisolone—psoriatic arthritis	0.000146	0.000525	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—psoriatic arthritis	0.000146	0.000525	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—psoriatic arthritis	0.000146	0.000525	CcSEcCtD
Sunitinib—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000145	0.000521	CcSEcCtD
Sunitinib—Diarrhoea—Betamethasone—psoriatic arthritis	0.000145	0.000521	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00014	0.000505	CcSEcCtD
Sunitinib—Dizziness—Betamethasone—psoriatic arthritis	0.00014	0.000504	CcSEcCtD
Sunitinib—Dizziness—Dexamethasone—psoriatic arthritis	0.00014	0.000504	CcSEcCtD
Sunitinib—Insomnia—Methotrexate—psoriatic arthritis	0.000139	0.000502	CcSEcCtD
Sunitinib—Nausea—Triamcinolone—psoriatic arthritis	0.000139	0.000499	CcSEcCtD
Sunitinib—Paraesthesia—Methotrexate—psoriatic arthritis	0.000138	0.000498	CcSEcCtD
Sunitinib—Nausea—Methylprednisolone—psoriatic arthritis	0.000138	0.000498	CcSEcCtD
Sunitinib—Dyspnoea—Methotrexate—psoriatic arthritis	0.000137	0.000494	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisone—psoriatic arthritis	0.000136	0.000489	CcSEcCtD
Sunitinib—Dyspepsia—Methotrexate—psoriatic arthritis	0.000136	0.000488	CcSEcCtD
Sunitinib—Vomiting—Dexamethasone—psoriatic arthritis	0.000135	0.000485	CcSEcCtD
Sunitinib—Vomiting—Betamethasone—psoriatic arthritis	0.000135	0.000485	CcSEcCtD
Sunitinib—Decreased appetite—Methotrexate—psoriatic arthritis	0.000134	0.000482	CcSEcCtD
Sunitinib—Rash—Betamethasone—psoriatic arthritis	0.000134	0.000481	CcSEcCtD
Sunitinib—Rash—Dexamethasone—psoriatic arthritis	0.000134	0.000481	CcSEcCtD
Sunitinib—Dermatitis—Dexamethasone—psoriatic arthritis	0.000133	0.00048	CcSEcCtD
Sunitinib—Dermatitis—Betamethasone—psoriatic arthritis	0.000133	0.00048	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000133	0.000479	CcSEcCtD
Sunitinib—Fatigue—Methotrexate—psoriatic arthritis	0.000133	0.000478	CcSEcCtD
Sunitinib—Headache—Betamethasone—psoriatic arthritis	0.000133	0.000477	CcSEcCtD
Sunitinib—Headache—Dexamethasone—psoriatic arthritis	0.000133	0.000477	CcSEcCtD
Sunitinib—Asthenia—Prednisone—psoriatic arthritis	0.000132	0.000476	CcSEcCtD
Sunitinib—Pain—Methotrexate—psoriatic arthritis	0.000132	0.000474	CcSEcCtD
Sunitinib—Pruritus—Prednisone—psoriatic arthritis	0.000131	0.00047	CcSEcCtD
Sunitinib—Diarrhoea—Prednisone—psoriatic arthritis	0.000126	0.000454	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000126	0.000454	CcSEcCtD
Sunitinib—Nausea—Betamethasone—psoriatic arthritis	0.000126	0.000453	CcSEcCtD
Sunitinib—Nausea—Dexamethasone—psoriatic arthritis	0.000126	0.000453	CcSEcCtD
Sunitinib—Dizziness—Prednisone—psoriatic arthritis	0.000122	0.000439	CcSEcCtD
Sunitinib—Abdominal pain—Methotrexate—psoriatic arthritis	0.000122	0.000438	CcSEcCtD
Sunitinib—Body temperature increased—Methotrexate—psoriatic arthritis	0.000122	0.000438	CcSEcCtD
Sunitinib—Vomiting—Prednisone—psoriatic arthritis	0.000117	0.000422	CcSEcCtD
Sunitinib—Rash—Prednisone—psoriatic arthritis	0.000116	0.000418	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—psoriatic arthritis	0.000116	0.000418	CcSEcCtD
Sunitinib—Headache—Prednisone—psoriatic arthritis	0.000116	0.000416	CcSEcCtD
Sunitinib—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000114	0.000409	CcSEcCtD
Sunitinib—Asthenia—Methotrexate—psoriatic arthritis	0.000111	0.000398	CcSEcCtD
Sunitinib—Nausea—Prednisone—psoriatic arthritis	0.00011	0.000394	CcSEcCtD
Sunitinib—Pruritus—Methotrexate—psoriatic arthritis	0.000109	0.000392	CcSEcCtD
Sunitinib—Diarrhoea—Methotrexate—psoriatic arthritis	0.000105	0.000379	CcSEcCtD
Sunitinib—Dizziness—Methotrexate—psoriatic arthritis	0.000102	0.000367	CcSEcCtD
Sunitinib—Vomiting—Methotrexate—psoriatic arthritis	9.8e-05	0.000353	CcSEcCtD
Sunitinib—Rash—Methotrexate—psoriatic arthritis	9.72e-05	0.00035	CcSEcCtD
Sunitinib—Dermatitis—Methotrexate—psoriatic arthritis	9.71e-05	0.000349	CcSEcCtD
Sunitinib—Headache—Methotrexate—psoriatic arthritis	9.66e-05	0.000347	CcSEcCtD
Sunitinib—Nausea—Methotrexate—psoriatic arthritis	9.16e-05	0.000329	CcSEcCtD
Sunitinib—IRAK4—Innate Immune System—CRP—psoriatic arthritis	7.46e-05	0.000269	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HLA-C—psoriatic arthritis	7.41e-05	0.000267	CbGpPWpGaD
Sunitinib—MAP2K2—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	7.38e-05	0.000266	CbGpPWpGaD
Sunitinib—JAK2—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	7.35e-05	0.000265	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—NOD2—psoriatic arthritis	7.35e-05	0.000265	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—HLA-C—psoriatic arthritis	7.34e-05	0.000264	CbGpPWpGaD
Sunitinib—FGR—Innate Immune System—HLA-B—psoriatic arthritis	7.32e-05	0.000264	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HLA-C—psoriatic arthritis	7.31e-05	0.000263	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—HLA-C—psoriatic arthritis	7.3e-05	0.000263	CbGpPWpGaD
Sunitinib—RPS6KA3—Innate Immune System—CRP—psoriatic arthritis	7.26e-05	0.000262	CbGpPWpGaD
Sunitinib—BLK—Immune System—HLA-C—psoriatic arthritis	7.23e-05	0.000261	CbGpPWpGaD
Sunitinib—FGR—Immune System—HLA-C—psoriatic arthritis	7.21e-05	0.00026	CbGpPWpGaD
Sunitinib—ITK—Immune System—CRP—psoriatic arthritis	7.17e-05	0.000259	CbGpPWpGaD
Sunitinib—BLK—Adaptive Immune System—HLA-B—psoriatic arthritis	7.05e-05	0.000254	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HLA-C—psoriatic arthritis	7.04e-05	0.000254	CbGpPWpGaD
Sunitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	7e-05	0.000252	CbGpPWpGaD
Sunitinib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.98e-05	0.000252	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—HLA-C—psoriatic arthritis	6.97e-05	0.000251	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—NOD2—psoriatic arthritis	6.97e-05	0.000251	CbGpPWpGaD
Sunitinib—MAP2K2—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	6.96e-05	0.000251	CbGpPWpGaD
Sunitinib—MAP2K1—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	6.91e-05	0.000249	CbGpPWpGaD
Sunitinib—ITK—Immune System—HLA-DRB1—psoriatic arthritis	6.87e-05	0.000248	CbGpPWpGaD
Sunitinib—TBK1—Immune System—NOD2—psoriatic arthritis	6.86e-05	0.000247	CbGpPWpGaD
Sunitinib—PAK3—Immune System—CRP—psoriatic arthritis	6.84e-05	0.000247	CbGpPWpGaD
Sunitinib—PHKG2—Disease—NOS2—psoriatic arthritis	6.78e-05	0.000244	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—NOD2—psoriatic arthritis	6.77e-05	0.000244	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—HLA-B—psoriatic arthritis	6.75e-05	0.000243	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—NOD2—psoriatic arthritis	6.73e-05	0.000243	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—HLA-B—psoriatic arthritis	6.68e-05	0.000241	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—NOD2—psoriatic arthritis	6.68e-05	0.000241	CbGpPWpGaD
Sunitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	6.59e-05	0.000238	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—NOD2—psoriatic arthritis	6.58e-05	0.000237	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—NOD2—psoriatic arthritis	6.56e-05	0.000237	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—NOD2—psoriatic arthritis	6.56e-05	0.000237	CbGpPWpGaD
Sunitinib—PAK3—Immune System—HLA-DRB1—psoriatic arthritis	6.55e-05	0.000236	CbGpPWpGaD
Sunitinib—FGR—Hemostasis—NOS2—psoriatic arthritis	6.55e-05	0.000236	CbGpPWpGaD
Sunitinib—FYN—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	6.55e-05	0.000236	CbGpPWpGaD
Sunitinib—MAP2K1—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	6.51e-05	0.000235	CbGpPWpGaD
Sunitinib—FGR—Innate Immune System—CRP—psoriatic arthritis	6.47e-05	0.000233	CbGpPWpGaD
Sunitinib—YES1—Immune System—REL—psoriatic arthritis	6.32e-05	0.000228	CbGpPWpGaD
Sunitinib—KCNH2—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	6.32e-05	0.000228	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—NOD2—psoriatic arthritis	6.23e-05	0.000224	CbGpPWpGaD
Sunitinib—JAK2—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	6.22e-05	0.000224	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—NOD2—psoriatic arthritis	6.21e-05	0.000224	CbGpPWpGaD
Sunitinib—CSNK2A1—Developmental Biology—TNF—psoriatic arthritis	6.21e-05	0.000224	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—NOD2—psoriatic arthritis	6.12e-05	0.00022	CbGpPWpGaD
Sunitinib—PAK3—Developmental Biology—TNF—psoriatic arthritis	6.02e-05	0.000217	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—HLA-B—psoriatic arthritis	6e-05	0.000216	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—REL—psoriatic arthritis	6e-05	0.000216	CbGpPWpGaD
Sunitinib—BLK—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.97e-05	0.000215	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—CRP—psoriatic arthritis	5.97e-05	0.000215	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—NOD2—psoriatic arthritis	5.95e-05	0.000214	CbGpPWpGaD
Sunitinib—CSNK2A1—Disease—NOS2—psoriatic arthritis	5.94e-05	0.000214	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—HLA-B—psoriatic arthritis	5.91e-05	0.000213	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—CRP—psoriatic arthritis	5.91e-05	0.000213	CbGpPWpGaD
Sunitinib—TYK2—Immune System—REL—psoriatic arthritis	5.82e-05	0.00021	CbGpPWpGaD
Sunitinib—YES1—Immune System—HLA-C—psoriatic arthritis	5.82e-05	0.00021	CbGpPWpGaD
Sunitinib—MAP2K2—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	5.76e-05	0.000208	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—REL—psoriatic arthritis	5.75e-05	0.000207	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—NOD2—psoriatic arthritis	5.73e-05	0.000207	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—HLA-DRB1—psoriatic arthritis	5.72e-05	0.000206	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—HLA-B—psoriatic arthritis	5.67e-05	0.000205	CbGpPWpGaD
Sunitinib—MAP3K7—MAPK Signaling Pathway—TNF—psoriatic arthritis	5.67e-05	0.000204	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—HLA-DRB1—psoriatic arthritis	5.66e-05	0.000204	CbGpPWpGaD
Sunitinib—KIT—Immune System—REL—psoriatic arthritis	5.65e-05	0.000204	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—REL—psoriatic arthritis	5.65e-05	0.000204	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—HLA-B—psoriatic arthritis	5.6e-05	0.000202	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—NOD2—psoriatic arthritis	5.6e-05	0.000202	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HLA-C—psoriatic arthritis	5.52e-05	0.000199	CbGpPWpGaD
Sunitinib—TBK1—Immune System—HLA-B—psoriatic arthritis	5.52e-05	0.000199	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—NOD2—psoriatic arthritis	5.45e-05	0.000196	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—HLA-B—psoriatic arthritis	5.44e-05	0.000196	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—HLA-B—psoriatic arthritis	5.42e-05	0.000195	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—NOD2—psoriatic arthritis	5.39e-05	0.000194	CbGpPWpGaD
Sunitinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	5.39e-05	0.000194	CbGpPWpGaD
Sunitinib—FGFR1—MAPK Signaling Pathway—TNF—psoriatic arthritis	5.38e-05	0.000194	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—HLA-B—psoriatic arthritis	5.37e-05	0.000194	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—NOD2—psoriatic arthritis	5.37e-05	0.000193	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—REL—psoriatic arthritis	5.36e-05	0.000193	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HLA-C—psoriatic arthritis	5.36e-05	0.000193	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—REL—psoriatic arthritis	5.35e-05	0.000193	CbGpPWpGaD
Sunitinib—BLK—Immune System—NOD2—psoriatic arthritis	5.32e-05	0.000192	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—CRP—psoriatic arthritis	5.31e-05	0.000191	CbGpPWpGaD
Sunitinib—FGR—Immune System—NOD2—psoriatic arthritis	5.3e-05	0.000191	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HLA-C—psoriatic arthritis	5.29e-05	0.000191	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—NOS2—psoriatic arthritis	5.29e-05	0.000191	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—HLA-B—psoriatic arthritis	5.29e-05	0.000191	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—HLA-B—psoriatic arthritis	5.28e-05	0.00019	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—HLA-B—psoriatic arthritis	5.28e-05	0.00019	CbGpPWpGaD
Sunitinib—RPS6KA5—Developmental Biology—TNF—psoriatic arthritis	5.25e-05	0.000189	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—CRP—psoriatic arthritis	5.22e-05	0.000188	CbGpPWpGaD
Sunitinib—RPS6KA2—Developmental Biology—TNF—psoriatic arthritis	5.2e-05	0.000187	CbGpPWpGaD
Sunitinib—KIT—Immune System—HLA-C—psoriatic arthritis	5.2e-05	0.000187	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HLA-C—psoriatic arthritis	5.2e-05	0.000187	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—HLA-B—psoriatic arthritis	5.16e-05	0.000186	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—NOD2—psoriatic arthritis	5.13e-05	0.000185	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—HLA-DRB1—psoriatic arthritis	5.08e-05	0.000183	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—HLA-B—psoriatic arthritis	5.07e-05	0.000183	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—HLA-B—psoriatic arthritis	5.07e-05	0.000183	CbGpPWpGaD
Sunitinib—EPHB6—Developmental Biology—TNF—psoriatic arthritis	5.05e-05	0.000182	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—HLA-B—psoriatic arthritis	5.01e-05	0.000181	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—HLA-B—psoriatic arthritis	5e-05	0.00018	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—CRP—psoriatic arthritis	4.95e-05	0.000179	CbGpPWpGaD
Sunitinib—MAP2K2—MAPK Signaling Pathway—TNF—psoriatic arthritis	4.95e-05	0.000178	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—REL—psoriatic arthritis	4.94e-05	0.000178	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HLA-C—psoriatic arthritis	4.93e-05	0.000178	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HLA-C—psoriatic arthritis	4.92e-05	0.000177	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—HLA-B—psoriatic arthritis	4.92e-05	0.000177	CbGpPWpGaD
Sunitinib—TBK1—Immune System—CRP—psoriatic arthritis	4.88e-05	0.000176	CbGpPWpGaD
Sunitinib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	4.85e-05	0.000175	CbGpPWpGaD
Sunitinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	4.84e-05	0.000174	CbGpPWpGaD
Sunitinib—PDGFRB—MAPK Signaling Pathway—TNF—psoriatic arthritis	4.83e-05	0.000174	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—REL—psoriatic arthritis	4.82e-05	0.000174	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—CRP—psoriatic arthritis	4.81e-05	0.000173	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—HLA-B—psoriatic arthritis	4.81e-05	0.000173	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.8e-05	0.000173	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—HLA-B—psoriatic arthritis	4.8e-05	0.000173	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—CRP—psoriatic arthritis	4.79e-05	0.000173	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—HLA-B—psoriatic arthritis	4.78e-05	0.000172	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—CRP—psoriatic arthritis	4.75e-05	0.000171	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—NOS2—psoriatic arthritis	4.74e-05	0.000171	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—CRP—psoriatic arthritis	4.68e-05	0.000169	CbGpPWpGaD
Sunitinib—TBK1—Immune System—HLA-DRB1—psoriatic arthritis	4.67e-05	0.000168	CbGpPWpGaD
Sunitinib—RPS6KA1—Developmental Biology—TNF—psoriatic arthritis	4.67e-05	0.000168	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—CRP—psoriatic arthritis	4.66e-05	0.000168	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—CRP—psoriatic arthritis	4.66e-05	0.000168	CbGpPWpGaD
Sunitinib—FYN—Immune System—REL—psoriatic arthritis	4.64e-05	0.000167	CbGpPWpGaD
Sunitinib—MAP2K1—MAPK Signaling Pathway—TNF—psoriatic arthritis	4.63e-05	0.000167	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—REL—psoriatic arthritis	4.62e-05	0.000166	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—HLA-B—psoriatic arthritis	4.61e-05	0.000166	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—HLA-DRB1—psoriatic arthritis	4.58e-05	0.000165	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-C—psoriatic arthritis	4.54e-05	0.000164	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—HLA-B—psoriatic arthritis	4.5e-05	0.000162	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—HLA-DRB1—psoriatic arthritis	4.48e-05	0.000161	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-C—psoriatic arthritis	4.43e-05	0.00016	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—CRP—psoriatic arthritis	4.43e-05	0.00016	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—CRP—psoriatic arthritis	4.42e-05	0.000159	CbGpPWpGaD
Sunitinib—JAK2—Immune System—REL—psoriatic arthritis	4.41e-05	0.000159	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HLA-B—psoriatic arthritis	4.38e-05	0.000158	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.37e-05	0.000157	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—CRP—psoriatic arthritis	4.35e-05	0.000157	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—HLA-B—psoriatic arthritis	4.34e-05	0.000156	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HLA-B—psoriatic arthritis	4.32e-05	0.000156	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—HLA-B—psoriatic arthritis	4.31e-05	0.000156	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.29e-05	0.000155	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.29e-05	0.000155	CbGpPWpGaD
Sunitinib—YES1—Immune System—NOD2—psoriatic arthritis	4.28e-05	0.000154	CbGpPWpGaD
Sunitinib—BLK—Immune System—HLA-B—psoriatic arthritis	4.28e-05	0.000154	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-C—psoriatic arthritis	4.27e-05	0.000154	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—NOS2—psoriatic arthritis	4.27e-05	0.000154	CbGpPWpGaD
Sunitinib—FGR—Immune System—HLA-B—psoriatic arthritis	4.26e-05	0.000154	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-C—psoriatic arthritis	4.25e-05	0.000153	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CRP—psoriatic arthritis	4.23e-05	0.000152	CbGpPWpGaD
Sunitinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	4.18e-05	0.000151	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HLA-B—psoriatic arthritis	4.17e-05	0.00015	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—HLA-DRB1—psoriatic arthritis	4.16e-05	0.00015	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—HLA-B—psoriatic arthritis	4.12e-05	0.000149	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—CRP—psoriatic arthritis	4.08e-05	0.000147	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.07e-05	0.000147	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-C—psoriatic arthritis	4.06e-05	0.000146	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.06e-05	0.000146	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—NOD2—psoriatic arthritis	4.06e-05	0.000146	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—HLA-DRB1—psoriatic arthritis	4.05e-05	0.000146	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—CRP—psoriatic arthritis	3.98e-05	0.000143	CbGpPWpGaD
Sunitinib—TYK2—Immune System—NOD2—psoriatic arthritis	3.94e-05	0.000142	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—NOD2—psoriatic arthritis	3.89e-05	0.00014	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—NOS2—psoriatic arthritis	3.88e-05	0.00014	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CRP—psoriatic arthritis	3.87e-05	0.00014	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—CRP—psoriatic arthritis	3.83e-05	0.000138	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—NOS2—psoriatic arthritis	3.83e-05	0.000138	CbGpPWpGaD
Sunitinib—KIT—Immune System—NOD2—psoriatic arthritis	3.82e-05	0.000138	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—NOD2—psoriatic arthritis	3.82e-05	0.000138	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—CRP—psoriatic arthritis	3.81e-05	0.000137	CbGpPWpGaD
Sunitinib—BLK—Immune System—CRP—psoriatic arthritis	3.78e-05	0.000136	CbGpPWpGaD
Sunitinib—FGR—Immune System—CRP—psoriatic arthritis	3.77e-05	0.000136	CbGpPWpGaD
Sunitinib—RPS6KA3—Developmental Biology—TNF—psoriatic arthritis	3.72e-05	0.000134	CbGpPWpGaD
Sunitinib—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	3.71e-05	0.000134	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HLA-DRB1—psoriatic arthritis	3.71e-05	0.000134	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—NOS2—psoriatic arthritis	3.69e-05	0.000133	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	3.66e-05	0.000132	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—CRP—psoriatic arthritis	3.64e-05	0.000131	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—NOD2—psoriatic arthritis	3.63e-05	0.000131	CbGpPWpGaD
Sunitinib—BLK—Immune System—HLA-DRB1—psoriatic arthritis	3.62e-05	0.000131	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—NOD2—psoriatic arthritis	3.62e-05	0.00013	CbGpPWpGaD
Sunitinib—FGR—Immune System—HLA-DRB1—psoriatic arthritis	3.61e-05	0.00013	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	3.53e-05	0.000127	CbGpPWpGaD
Sunitinib—YES1—Immune System—HLA-B—psoriatic arthritis	3.44e-05	0.000124	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—NOD2—psoriatic arthritis	3.34e-05	0.00012	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—TNF—psoriatic arthritis	3.28e-05	0.000118	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HLA-B—psoriatic arthritis	3.26e-05	0.000118	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—NOD2—psoriatic arthritis	3.26e-05	0.000117	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HLA-B—psoriatic arthritis	3.17e-05	0.000114	CbGpPWpGaD
Sunitinib—FYN—Immune System—NOD2—psoriatic arthritis	3.14e-05	0.000113	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HLA-B—psoriatic arthritis	3.13e-05	0.000113	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—NOD2—psoriatic arthritis	3.13e-05	0.000113	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—TNF—psoriatic arthritis	3.08e-05	0.000111	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HLA-B—psoriatic arthritis	3.07e-05	0.000111	CbGpPWpGaD
Sunitinib—KIT—Immune System—HLA-B—psoriatic arthritis	3.07e-05	0.000111	CbGpPWpGaD
Sunitinib—YES1—Immune System—CRP—psoriatic arthritis	3.04e-05	0.00011	CbGpPWpGaD
Sunitinib—JAK2—Immune System—NOD2—psoriatic arthritis	2.99e-05	0.000108	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HLA-B—psoriatic arthritis	2.92e-05	0.000105	CbGpPWpGaD
Sunitinib—YES1—Immune System—HLA-DRB1—psoriatic arthritis	2.91e-05	0.000105	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HLA-B—psoriatic arthritis	2.91e-05	0.000105	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CRP—psoriatic arthritis	2.89e-05	0.000104	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CRP—psoriatic arthritis	2.8e-05	0.000101	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CRP—psoriatic arthritis	2.77e-05	9.97e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HLA-DRB1—psoriatic arthritis	2.76e-05	9.96e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CRP—psoriatic arthritis	2.72e-05	9.79e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CRP—psoriatic arthritis	2.72e-05	9.79e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-B—psoriatic arthritis	2.69e-05	9.68e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HLA-DRB1—psoriatic arthritis	2.68e-05	9.67e-05	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—TNF—psoriatic arthritis	2.68e-05	9.65e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HLA-DRB1—psoriatic arthritis	2.65e-05	9.55e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-B—psoriatic arthritis	2.62e-05	9.45e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—HLA-DRB1—psoriatic arthritis	2.6e-05	9.38e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HLA-DRB1—psoriatic arthritis	2.6e-05	9.38e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CRP—psoriatic arthritis	2.58e-05	9.29e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CRP—psoriatic arthritis	2.57e-05	9.27e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-B—psoriatic arthritis	2.53e-05	9.11e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-B—psoriatic arthritis	2.51e-05	9.06e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HLA-DRB1—psoriatic arthritis	2.47e-05	8.9e-05	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—TNF—psoriatic arthritis	2.47e-05	8.88e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HLA-DRB1—psoriatic arthritis	2.46e-05	8.88e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-B—psoriatic arthritis	2.4e-05	8.66e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CRP—psoriatic arthritis	2.37e-05	8.56e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—NOS2—psoriatic arthritis	2.36e-05	8.5e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—NOS2—psoriatic arthritis	2.33e-05	8.39e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CRP—psoriatic arthritis	2.32e-05	8.35e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—NOS2—psoriatic arthritis	2.29e-05	8.24e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-DRB1—psoriatic arthritis	2.27e-05	8.19e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—TNF—psoriatic arthritis	2.27e-05	8.18e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CRP—psoriatic arthritis	2.23e-05	8.05e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CRP—psoriatic arthritis	2.22e-05	8.01e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-DRB1—psoriatic arthritis	2.22e-05	8e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NOS2—psoriatic arthritis	2.17e-05	7.82e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NOS2—psoriatic arthritis	2.17e-05	7.8e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-DRB1—psoriatic arthritis	2.14e-05	7.71e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-DRB1—psoriatic arthritis	2.13e-05	7.67e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CRP—psoriatic arthritis	2.12e-05	7.65e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—TNF—psoriatic arthritis	2.09e-05	7.53e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-DRB1—psoriatic arthritis	2.03e-05	7.33e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NOS2—psoriatic arthritis	2e-05	7.2e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—TNF—psoriatic arthritis	1.97e-05	7.08e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—TNF—psoriatic arthritis	1.95e-05	7.05e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NOS2—psoriatic arthritis	1.95e-05	7.03e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—NOS2—psoriatic arthritis	1.88e-05	6.78e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NOS2—psoriatic arthritis	1.87e-05	6.74e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—TNF—psoriatic arthritis	1.87e-05	6.73e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.83e-05	6.61e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—NOS2—psoriatic arthritis	1.79e-05	6.44e-05	CbGpPWpGaD
